Short description
Soteria is a biotechnology company that develops immunotherapies to treat cancer patients
Description
Soteria is developing a next generation of conditionally active bispecific t-cell engaging antibodies to treat cancer patients with solid tumors. Soteria’s highly innovative T-LITE™ platform provides small molecule-dependent activation of bispecific antibody therapies, enabling safer and more efficacious treatments through pulsatile activity, reduced side effects and higher dosing.
Last funding
No Way
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
San Francisco, California, United States, North America
Founded on
January 1, 2018
Non-profit?
No
Acquired?
No
Employees count
11-50
Investors
Noaccessforu, Noway Youcantaccess, Uh Ohhhh, Noaccessforu, Noway Youcantaccess
Sign in for full access
Founders
Alexander Martinko, James Wells, Zachary Hill